My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Could SpaceX Overtake Nvidia As The World's B...
Intel-Backed Mobileye's Robotaxi Ambitions Ju...
CoreWeave Is 'Woefully Undervalued', Says Ana...
Netflix Flexes 'M&A Muscle' As Bidding Contes...
AI Data Center Resistance Sweeps The US As $1...
SpaceX To Buy AI Coding Startup Cursor
Moderna Strengthens Commercial Strategy As Pi...
Yum China Buys Pizza Hut Brand In China
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    VIR BIOTECHNOLOGY INC (NASDAQ: VIR)

    Overview
    current price
    $8.61
    $8.61
    change
    0.00 | 0.00%
    0.00 | 0.00%
    Yesterday's Close
    8.61
    open
    8.62
    volume
    1.38 M
    30d. avg volume.
    1.61 M
    1 day
    8.49 - 8.73
    52 weeks
    4.16 - 11.66
    p/e
    0.00
    beta
    1.6530
    market cap
    1.45 B
    dividend yield
    0.00%
    Industry
    -
    VIR by TradingView
    News and Commentary
    Regeneron is Working on New Antibody Therapy for Omicron, Rival Therapies Show Mixed Results Against... Following lackluster data on the effectiveness of its COVID antibody therapy against the high mutated Omicron variant, Regeneron
    Market Update: Dow Reaches New Record Close on Verizon and Chevron Gains Stocks ended Wednesday's session mixed, with the Dow Jones rising to another record close while the S&P 500 and Nasdaq slipped lower. The S&P 500 had pared losses in late afterno...
    Market Update: Stocks May be Rallying Too Soon, United States Braces for Tough Week Ahead Investors on Wall Street lead a stock market rally on Monday on the back of weekend data that shows that social distancing measures in the U.S. may be working to slow the spread...
    IPO Update: Pharmaceuticals Stumble into the Market Two of the three recently priced public companies have fallen below their share prices, demonstrating fears of the IPO market not being very friendly since the downfall of WeWork...
    StockTwits
    StockTwits
    Most Shared
    IBM Is Chasing A '$1 Trillion Value Creation Engine' — And It's Spending $15 Billion To Get There
    Best Buy Stock Pops After Strong Comparable Sales, Margin Growth
    US Says China To Buy At Least $17 Billion Worth Agricultural Goods Annually After Trump-Xi Meet
    Most Popular
    Meta's $125 Billion AI Bet Might Be The Capex Trap Of The Decade
    AI's Memory Shortage Runs Into 2028 — Goldman Stays Bullish On SanDisk, Samsung, SK Hynix
    The AI Spending Boom Just Got Bigger: Goldman Sees $800 Billion Flowing In This Year
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Tesla
    Coronavirus Impact
    Google
    China
    Covid-19
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?